Search the Newsreel

EpicQuest Education Group International Ltd (EEIQ) Balance Sheet

This article provides the balance sheet for EpicQuest Education Group International Ltd (EEIQ), presenting detailed quarterly and annual financial data. It allows users to evaluate the company's financial health by analyzing assets, liabilities, and shareholders' equity. The data covers periods from FY2021H1 to FY2025H1, …

ETS|Elite Express Holding Inc|Price:1.105|Chg%:+0.040

ETS|Elite Express Holding Inc|Price:1.130|

EpicQuest Education Group International Ltd (EEIQ) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for EpicQuest Education Group International Ltd (EEIQ), detailing its volatility, financial risk, and investment risk. It includes key metrics such as Beta, VaR, Maximum Drawdown, Volatility, Sharpe Ratio, and daily returns over various periods. The assessment also covers …

Belite Bio Inc (BLTE) Valuation: PE, PB & Fair Value Analysis

This article provides a brief valuation analysis for Belite Bio Inc (BLTE), focusing on its P/E, P/B, and P/CF ratios. It states that relevant data for these metrics have not yet been disclosed by the company. The page also displays the current stock price, …

EpicQuest Education Group International Ltd (EEIQ) Technical Analysis: Support, Resistance, Indicators & Moving Averages — TradingKey

This article provides a technical analysis of EpicQuest Education Group International Ltd (EEIQ) stock, detailing various indicators and moving averages. It offers a summary of "Sell" signals for indicators like MACD, CCI, Williams %R, TRIX, and StochRSI, and "Sell" signals across all listed moving …

EpicQuest Education Group International Ltd (EEIQ) Institutional Confidence

This article provides details on the institutional confidence in EpicQuest Education Group International Ltd (EEIQ), presenting a list of key shareholders and their reported shareholdings in the company. It indicates changes in holdings for some investors, highlighting increased stakes by Zhang (Jianbo), Wu (Zhenyu), …

Belite Bio Inc (BLTE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article for Belite Bio Inc (BLTE) on TradingKey discusses the company's revenue breakdown. It states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The article provides current stock performance details like market …

Belite Bio Inc (BLTE) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Belite Bio Inc (BLTE), focusing on its volatility, financial risk, and overall investment risk. It details various metrics including Beta, VaR, Maximum Drawdown, Volatility, Sharpe Ratio, and Liquidity. The data indicates significant volatility and downside risk for …

EEIQ Cash Flow Statement

This article provides the quarterly and annual cash flow statements for EpicQuest Education Group International Ltd (EEIQ), allowing users to assess its financial health. It details operating, investing, and financing cash flows, along with free cash flow, and includes FAQs explaining these financial concepts …

EEIQ|EpicQuest Education Group International Ltd|Price:2.270|Chg%:+0.135

This article provides an overview and analysis of EpicQuest Education Group International Ltd (EEIQ) stock. It details the methodologies TradingKey uses to generate various stock scores, including financial health, company valuation, earnings forecast, price momentum, institutional confidence, and risk management. The article notes that …

EpicQuest Education Group International Ltd (EEIQ) Income Statement

This article provides the income statement for EpicQuest Education Group International Ltd (EEIQ), detailing quarterly and annual financial performance from FY2021H1 to FY2024H2. It covers key metrics like total revenue, cost of revenue, operating expenses, operating profit, and net income, showing the company's financial …

Price to sales forward of Belite Bio, Inc. ADR – FWB:D01

This article provides access to the "Price to sales forward" financial metric for Belite Bio, Inc. ADR (FWB:D01) on the Frankfurt Stock Exchange. It indicates that the market is closed with no current trades. The content primarily serves as a gateway to financial data …

Belite Bio Inc (BLTE) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Belite Bio Inc (BLTE), identifying its major shareholders and institutional holdings. It provides breakdowns of shareholder types, institutional shareholding over recent quarters, and individual shareholder activity, highlighting key investors like Lin Bioscience International, Ltd. and Darwin Global …

Belite Bio Inc (BLTE) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Belite Bio Inc (BLTE), detailing analyst ratings, price targets, and historical and projected EPS. Based on 8 analysts' opinions, the stock has a "Buy" rating with an average target price of USD 210.50, representing a potential upside …

Belite Bio, Inc. ADR Revenue Breakdown – FWB:D01

This article focuses on the revenue breakdown for Belite Bio, Inc. ADR (D01) on the Frankfurt Stock Exchange. It indicates that the company's market is currently closed with no trades. The main content points to various financial data and tools available on TradingView for …

Belite Bio Conference Highlights Tinlarebant Data and New Hope for Retinal Diseases

A recent H.C. Wainwright conference highlighted advancements in treating inherited retinal diseases, particularly Stargardt disease and retinitis pigmentosa. Belite Bio presented positive data for its drug tinlarebant, showing a significant reduction in macular lesion growth for Stargardt disease, while Nanoscope Therapeutics showcased MCO-010 as …

Belite Bio (BLTE) Leerink’s Global Healthcare Conference 2025 Summary

This article summarizes Belite Bio's presentation at Leerink's Global Healthcare Conference 2025, focusing on their drug Tinlarebant for Stargardt disease and geographic atrophy. The summary details the disease background, drug mechanism, clinical trial designs (Phase II, DRAGON, DRAGON 2, and GA studies), and efficacy …

Belite Bio stock price target maintained at $200 by H.C. Wainwright

H.C. Wainwright has reiterated a Buy rating and a $200 price target for Belite Bio (NASDAQ:BLTE), citing positive secondary endpoint data from its Phase 3 DRAGON trial for tinlarebant in Stargardt disease type 1. The stock has seen a 170% return over the past …

Belite Bio, Inc (BLTE) Stock Analysis: A 37.73% Upside Potential in the Biotechnology Sector

Belite Bio, Inc (BLTE) is a clinical-stage biopharmaceutical company with a promising 37.73% upside potential, according to analyst ratings. The company is focused on developing therapies for Stargardt disease type 1 and geographic atrophy, with its lead product Tinlarebant (LBS-008) in phase 3 clinical …

EpicQuest Education Announces New AI Tutorial Platform

EpicQuest Education Group International Limited (NASDAQ: EEIQ) has announced the beta testing of its new AI tutoring platform for students at Davis University and Davis Academy, with a full launch expected in September. The platform aims to provide individualized, adaptive learning, real-time feedback, and …

EpicQuest Education begins beta testing AI tutoring platform By Investing.com

EpicQuest Education Group International Limited (NASDAQ:EEIQ) is beta testing an AI tutoring platform for students at Davis University and Davis Academy in July, with a full launch planned for September. This platform aims to provide personalized learning support, real-time feedback, and 24/7 availability with …

EpicQuest Education Announces Beta Testing of AI Tutoring Platform for Davis University and Davis Academy Students

EpicQuest Education Group International Limited (EEIQ) has initiated beta testing for its new AI tutoring platform among students at Davis University and Davis Academy, with a full launch planned for September. This platform aims to provide personalized, adaptive learning with 24/7 availability and multilingual …

EpicQuest students will test an always-available AI tutor

EpicQuest Education (NASDAQ: EEIQ) is commencing a beta test of its new AI tutoring platform for students at Davis University and Davis Academy in July 2026. The platform aims to provide individualized, adaptive learning with 24/7 access and multilingual support, blending AI with traditional …

Tinlarebant retinal marker stayed stable or fell ~2%; placebo rose 20%

Belite Bio reported additional positive secondary endpoint data from its Phase 3 DRAGON trial of tinlarebant for Stargardt disease type 1. The data, presented at ASRS 2026 Annual Meeting, showed that quantitative autofluorescence remained stable to slightly decreased in tinlarebant-treated subjects, while it increased …

Belite Bio completes FDA filing for tinlarebant in Stargardt disease type 1

Belite Bio has completed its New Drug Application (NDA) filing with the FDA for tinlarebant, aiming to treat Stargardt disease type 1. This news brief, generated by AI, is for informational purposes only and references original content published by Belite Bio via GlobeNewswire.

Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1

Belite Bio announced additional positive secondary endpoint data from its Phase 3 DRAGON trial of tinlarebant in Stargardt disease type 1 (STGD1), which demonstrated a marked divergence in quantitative autofluorescence (qAF) between treatment groups. Tinlarebant showed stable to slightly decreased qAF values, while placebo …

We Think Elite Express Holding (NASDAQ:ETS) Needs To Drive Business Growth Carefully

Elite Express Holding (NASDAQ:ETS) faces concerns due to its high cash burn rate, which increased by 1,563% in the last year, compared to a 13% growth in operating revenue. With a cash runway of only 9 months and a cash burn of US$7.0m against …

Responsive Playbooks and the BLTE Inflection

This article provides an in-depth AI-generated analysis of Belite Bio Inc (NASDAQ: BLTE), highlighting near-term weak sentiment challenging long-term strength. It presents institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also includes a multi-timeframe signal breakdown …

Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

Belite Bio, Inc. (NASDAQ: BLTE) announced its participation in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026, at 3:00 pm ET. The clinical-stage drug development company focuses on novel therapeutics for degenerative retinal diseases like Stargardt disease type 1 and …

Belite Bio's July 22 Ophthalmology Panel Will Be Online

Belite Bio (NASDAQ: BLTE) announced its participation in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on Wednesday, July 22, 2026, at 3:00 pm ET. The clinical-stage drug development company will join a panel discussion, and a live webcast with a 90-day replay will …

We Think That There Are Issues Underlying AME Elite Consortium Berhad's (KLSE:AME) Earnings

Capital A, Alliance Bank, Farm Fresh, Critical, Hibiscus Petroleum, Eonmetall, CSC Steel, Taliworks, Malaysia Smelting, PBA, Favelle Favco, AEON, Well Chip, AME Elite Consortium, Berjaya Food, Ann Joo, Paramount

Elite UK REIT: Resilient growth in distributable income

Elite UK REIT to Launch Dual Currency Trading on SGX in 2026

Here's Why We Think AME Elite Consortium Berhad (KLSE:AME) Might Deserve Your Attention Today